Akebia Therapeutics Inc (AKBA)
1.36
-0.01
(-0.73%)
USD |
NASDAQ |
Apr 23, 16:00
1.36
0.00 (0.00%)
After-Hours: 20:00
Akebia Therapeutics Price: 1.36 for April 23, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 23, 2024 | 1.38 | 1.41 | 1.35 | 1.37 | 2.082M |
| Apr 22, 2024 | 1.37 | 1.40 | 1.34 | 1.37 | 1.941M |
| Apr 19, 2024 | 1.35 | 1.38 | 1.31 | 1.36 | 2.956M |
| Apr 18, 2024 | 1.37 | 1.435 | 1.33 | 1.39 | 2.563M |
| Apr 17, 2024 | 1.40 | 1.42 | 1.36 | 1.39 | 2.944M |
| Apr 16, 2024 | 1.38 | 1.425 | 1.32 | 1.40 | 4.129M |
| Apr 15, 2024 | 1.42 | 1.45 | 1.39 | 1.39 | 3.898M |
| Apr 12, 2024 | 1.52 | 1.54 | 1.42 | 1.46 | 4.106M |
| Apr 11, 2024 | 1.55 | 1.55 | 1.47 | 1.53 | 3.155M |
| Apr 10, 2024 | 1.58 | 1.62 | 1.52 | 1.56 | 5.435M |
| Apr 09, 2024 | 1.50 | 1.56 | 1.47 | 1.54 | 3.604M |
| Apr 08, 2024 | 1.48 | 1.54 | 1.42 | 1.53 | 3.752M |
| Apr 05, 2024 | 1.51 | 1.56 | 1.48 | 1.49 | 3.657M |
| Apr 04, 2024 | 1.47 | 1.60 | 1.46 | 1.51 | 6.194M |
| Apr 03, 2024 | 1.59 | 1.59 | 1.43 | 1.49 | 8.637M |
| Apr 02, 2024 | 1.55 | 1.610 | 1.47 | 1.58 | 8.133M |
| Apr 01, 2024 | 1.875 | 1.93 | 1.55 | 1.63 | 14.08M |
| Mar 28, 2024 | 2.47 | 2.48 | 1.77 | 1.83 | 61.07M |
| Mar 27, 2024 | 2.06 | 2.335 | 2.045 | 2.24 | 10.58M |
| Mar 26, 2024 | 2.20 | 2.221 | 1.91 | 2.00 | 10.25M |
| Mar 25, 2024 | 2.24 | 2.330 | 2.148 | 2.21 | 8.573M |
| Mar 22, 2024 | 2.07 | 2.24 | 2.02 | 2.17 | 7.877M |
| Mar 21, 2024 | 1.96 | 2.08 | 1.94 | 2.04 | 6.559M |
| Mar 20, 2024 | 1.87 | 1.94 | 1.78 | 1.94 | 5.227M |
| Mar 19, 2024 | 1.88 | 1.937 | 1.792 | 1.83 | 4.344M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.25
Minimum
Nov 29 2022
13.58
Maximum
Jun 30 2020
3.234
Average
2.57
Median
Nov 04 2020
Price Benchmarks
| Ocugen Inc | 1.24 |
| Aquestive Therapeutics Inc | 4.27 |
| SELLAS Life Sciences Group Inc | 1.63 |
| Protagonist Therapeutics Inc | 26.85 |
| Stoke Therapeutics Inc | 11.25 |
Price Related Metrics
| PS Ratio | 1.309 |
| Earnings Yield | -20.59% |
| Market Cap | 284.75M |